Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study



Status:Completed
Healthy:No
Age Range:18 - Any
Updated:11/17/2018
Start Date:April 2015
End Date:July 2018

Use our guide to learn which trials are right for you!

Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study (PPIUD)

This is an observational study enrolling women who have had a copper intrauterine device
placed immediately after childbirth. The study follows participants for 6 month in order to
evaluate the primary outcome of IUD expulsion within 6 months of delivery.

The purpose of the study is to measure the rate of expulsion of the copper intrauterine
device (ParaGard®) when placed immediately after childbirth. Many women in the United States
have unintended pregnancies. Long-acting reversible birth control methods, like the copper
intrauterine device (IUD), help prevent unintended pregnancy. This is because, once in place,
the copper IUD provides excellent pregnancy prevention, and women using it do not have to do
anything extra to make sure it works (like taking a birth control pill every day, for
example). The copper IUD is safe and well liked among women who use it. Around the world,
women have been getting their IUD fitted right after childbirth for the past 20 years, and
this practice has been shown to be safe. This service has been offered at HUP since early
2014. When the IUD is placed after birth, there is a chance that it could fall out, as the
uterus shrinks back to its pre-pregnancy size. Women who get their IUD fitted right after
childbirth will be observed, and describe the rate of IUD expulsion at 6 months postpartum.
Factors associated with IUD expulsion will be noted. Adult pregnant women delivering at the
Hospital of the University of Pennsylvania, desiring an immediate IUD, and willing to follow
up 6 months after birth, will be eligible to participate.

Inclusion Criteria:

- Adult woman age 18 years or more

- Pregnant, 24 weeks 0 days gestation or more OR who have had a delivery at 34 weeks 0
days gestation or more

- Anticipating a delivery at the Hospital of the University of Pennsylvania

- Desiring an immediate postplacental TCu380A IUD, OR who have given birth and received
an immediate postplacental TCu380A IUD

- Able and willing to give consent in English

- Willing to follow up 6 months after delivery

Exclusion Criteria:

- Allergy or contraindication to TCu380A

- Known cervical cancer or carcinoma in situ

- History of undiagnosed abnormal vaginal bleeding prior to pregnancy

- Unwilling to follow up in the six months following delivery will be excluded

Additional exclusion criteria apply after delivery:

- Preterm delivery (33 weeks 6 days gestation or less at birth)

- Clinical diagnosis of chorioamnionitis or treatment for presumed chorioamnionitis

- No longer desiring immediate postplacental TCu380A placement

- Subjects aged less than 18 years

- Men are excluded by the nature of this women's health research.
We found this trial at
1
site
3400 Spruce St
Philadelphia, Pennsylvania 19104
 (215) 662-4000
Phone: 215-662-3532
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials